ACLARIS THERAPEUTICS INC. - COMMON STOCK
1.4000
04-April-25 16:45:00
15 minutes delayed
Stocks
-0.0900
-6.04%
Today's range
1.3400 - 1.4600
ISIN
N/A
Source
NASDAQ
-
30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
16 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
10 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Provides Corporate Update
19 Dec 2023 16:01:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia
05 Dec 2023 16:01:00 By Nasdaq GlobeNewswire
-
13 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
03 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
20 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
18 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
07 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
13 Jun 2023 11:09:02 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences
02 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
08 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023
02 May 2023 07:01:12 By Nasdaq GlobeNewswire
-
27 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
06 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
23 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Virtual SVB Securities Global Biopharma Conference
09 Feb 2023 16:01:00 By Nasdaq GlobeNewswire